SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-12-040294
Filing Date
2012-07-20
Accepted
2012-07-20 12:20:31
Documents
4
Period of Report
2012-07-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v319070_8k.htm 8-K 20358
2 EXHIBIT 99.1 v319070_ex99-1.htm EX-99.1 7341
3 EXHIBIT 99.2 v319070_ex99-2.htm EX-99.2 5155
4 GRAPHIC exlogo.jpg GRAPHIC 8611
  Complete submission text file 0001144204-12-040294.txt   46142
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10019
Business Address 110 EAST 59TH STREET NEW YORK NY 10019 250-519-0553
BRAINSTORM CELL THERAPEUTICS INC (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 912061050 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54365 | Film No.: 12971487
SIC: 2836 Biological Products, (No Diagnostic Substances)